The World's Health Care Crisis : From the Laboratory Bench to the Patient's Bedside

個数:
電子版価格
¥18,285
  • 電子版あり
  • ポイントキャンペーン

The World's Health Care Crisis : From the Laboratory Bench to the Patient's Bedside

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 296 p.
  • 言語 ENG
  • 商品コード 9780123918758
  • DDC分類 362.1

基本説明

An objective and in-depth analysis of the current state of the pharmaceutical and biotechnology industries and of the impact these industries have on global health care.

Full Description

At present, human society is facing a health care crisis that is affecting patients worldwide. In the United States, it is generally believed that the major problem is lack of affordable access to health care (i.e. health insurance). This book takes an unprecedented approach to address this issue by proposing that the major problem is not lack of affordable access to health care per se, but lack of access to better, safer, and more affordable medicines. The latter problem is present not only in the United States and the developing world but also in countries with socialized health care systems, such as Europe and the rest of the industrialized world. This book provides a comparative analysis of the health care systems throughout the world and also examines the biotechnology and pharmaceutical industries.

Contents

PART I: THE GLOBAL HEALTH CARE CRISIS

1. The World's Health Care Crisis: The United States' Leadership

2. The Health Care Crisis in Other Parts of the World

PART II: UNDERSTANDING THE BIOPHARMACEUTICAL BUSINESS

3. Brief Commercial History of the Biopharmaceutical Industry up to the Year 2000

4. The Biopharmaceutical Industry in the Twenty-first Century: Titanic Challenges Ahead

5. Understanding Research and Development and Marketing in a Biopharmaceutical Company

6. The Pharmaceutical Regulators

PART III: THE COMPLEXITY OF INNOVATION

7. The Academia-Industry Relationship

8. Translating Academic Innovation into Health Care Products

9. The Biotechnology World and Its Challenges

10. Causes of the Pharmaceutical Crisis

PART IV: MORALITY AND DUTY ON A LONELY PLANET

11. Wealth versus Poverty

12. Social Responsibility, Governmental Role, and Nongovernmental Organizations

PART V: REINVENTING RESEARCH AND DEVELOPMENT

13. Time for Reorganization

最近チェックした商品